2006N-0062
  

  
Expanded Access to Investigational Drugs for Treatment Use
  


  

  

  


  

  
FDA Comment Number : 
  

  
EC47
  



  

  
Submitter : 
  

  
Dr. Mary Ann McElligott
  

  
Date & Time: 
  

  
03/13/2007 06:03:48
  



  

  
Organization : 
  

  
Novo Nordisk Inc.
  



  

  
Category : 
  

  
Drug Industry
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
See Attachment
  


  

  



  

  
2006N-0062-EC47-Attach-1.PDF